Veeva Systems has acquired Cloud software and trial supply management services provider Veracity Logic, bolstering its end-to-end clinical portfolio.
The team of Veracity Logic will become part of Veeva to offer software and services, aiding firms to streamline intricate procedures and accelerate clinical trials.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe Veeva RTSM solution provides quick setup timelines and a flexible feature set to fulfil a wide range of randomisation and supply requirements.
The solution has so far supported more than 175 trials with study centres in 60 nations, encompassing a broad range of study designs and complexities in pharmaceutical/biotechnology, medical device and diagnostics areas.
Veeva Systems Vault R&D and Quality vice-president Jim Reilly said: “We are pleased to have the Veracity Logic team join Veeva and look forward to bringing RTSM excellence to our customers.
“This expands Veeva’s clinical offering with flexible and user-friendly RTSM capabilities.”
The company noted that it aims for continuity and transparency for Veeva RTSM clients, as well as partners such as Signant Health, Almac Group, 4G Clinical, S-CLINICA, and Suvoda.
Existing and new clients will be able to incorporate Veeva RTSM into any EDC system and utilise Veeva EDC with any RTSM system.
Veracity Logic founder Steve Zimmerman said: “This acquisition is great for our customers and employees.
“Joining Veeva allows us to scale our solution to a wider market while continuing to deliver customer success.”
Zimmerman will lead Veeva RTSM as general manager while current president David Goldston will resume the role of sales vice-president.
In October this year, Veeva launched the new Veeva Digital Trials Platform that enables execution of trials and data flow between stakeholders, without any interruption.